Thursday, May 7, 2026 at 9 a.m. ET. Call participants. President and Chief Executive Officer — Jack Azagury; Chief Financial ...
The timing of CHAPTER-3 topline results looms largest. The study tests whether deucrictibant’s extended-release tablet can prevent HAE attacks with once-daily oral dosing. RBC Capital notes the trial ...
States continue to debate and pass artificial intelligence (AI) laws at a rapid pace. The latest major statute poised to hit the books ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results